9780128140390-0128140399-Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives

Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives

ISBN-13: 9780128140390
ISBN-10: 0128140399
Edition: 1
Author: Nima Rezaei, Mahsa Keshavarz-Fathi
Publication date: 2018
Publisher: Academic Press
Format: Paperback 198 pages
FREE US shipping
Buy

From $138.00

Book details

ISBN-13: 9780128140390
ISBN-10: 0128140399
Edition: 1
Author: Nima Rezaei, Mahsa Keshavarz-Fathi
Publication date: 2018
Publisher: Academic Press
Format: Paperback 198 pages

Summary

Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (ISBN-13: 9780128140390 and ISBN-10: 0128140399), written by authors Nima Rezaei, Mahsa Keshavarz-Fathi, was published by Academic Press in 2018. With an overall rating of 4.0 stars, it's a notable title among other Biology (Biological Sciences) books. You can easily purchase or rent Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (Paperback) from BooksRun, along with many other new and used Biology books and textbooks. And, if you're looking to sell your copy, our current buyback offer is $0.3.

Description

Therapeutic cancer vaccines represent a type of active cancer immunotherapy. Clinicians, scientists, and researchers working on cancer treatment require evidence-based and up-to-date resources relating to therapeutic cancer vaccines. Vaccines for Cancer Immunotherapy provides a reference for cancer treatment for clinicians and presents a well-organized resource for determining high-potential research areas. The book considers that this promising modality can be made more feasible as a treatment for cancer. Chapters cover cancer immunology, general approaches to cancer immunotherapy, vaccines, tumor antigens, the strategy of allogeneic and autologous cancer vaccines, personalized vaccines, whole-tumor antigen vaccines, protein and peptide vaccines, dendritic cell vaccines, genetic vaccines, candidate cancers for vaccination, obstacles to developing therapeutic cancer vaccines, combination therapy, future perspectives and concluding remarks on therapeutic cancer vaccines.Introduces the feasible immunotherapeutic vaccines for patients with different types of cancerPresents the status of past and current vaccines for cancer treatmentConsiders advantages and disadvantages of different therapeutic cancer vaccinesLooks at the combination of vaccines and other modalities, including immunotherapeutic and conventional methodsAnalyzes obstacles to development of therapeutic cancer vaccinesGives a view on future perspectives in the application of therapeutic cancer vaccines
Rate this book Rate this book

We would LOVE it if you could help us and other readers by reviewing the book